Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
Conditions
- Chronic Myeloproliferative Disorders
- Kidney Cancer
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
Interventions
- BIOLOGICAL: anti-thymocyte globulin
- BIOLOGICAL: filgrastim
- BIOLOGICAL: graft-versus-tumor induction therapy
- BIOLOGICAL: therapeutic allogeneic lymphocytes
- DRUG: busulfan
- DRUG: cyclophosphamide
- DRUG: fludarabine phosphate
- DRUG: methotrexate
- DRUG: mycophenolate mofetil
- DRUG: tacrolimus
- PROCEDURE: allogeneic bone marrow transplantation
- PROCEDURE: nonmyeloablative allogeneic hematopoietic stem cell transplantation
- PROCEDURE: peripheral blood stem cell transplantation
Sponsor
University of California, San Francisco
Collaborators